Box Office: ‘Mortal Kombat II’ Earns $5M in Previews as ‘Prada 2’ Crosses $100M in U.S., $300M Globally

Mortal Kombat II opened with $5.2 million in Thursday previews and early Imax screenings, with Warner Bros. guiding to a $35 million to $40 million domestic opening and $65 million to $80 million worldwide. The article also highlights solid box office momentum for The Devil Wears Prada 2 and the Michael Jackson biopic, while Billie Eilish — Hit Me Hard and Soft: The Tour (Live in 3D) is tracking for a $6 million to $9 million launch and The Sheep Detectives for $12 million to $15 million.

Analysis

The key signal here is not the opening-level noise, but the widening dispersion between franchise quality and actual audience elasticity. Sequels with built-in recognition can still underperform when the prior installment was inflated by a unique distribution window; that makes current tracking a better read-through for near-term theatrical demand than legacy comparisons. The bigger second-order effect is that premium-format and eventized releases are increasingly being used to defend opening-weekend economics, which raises the hurdle for mid-budget genre films that rely on screens rather than fan urgency.

For exhibitors, a modest debut from the action title is not inherently negative if it preserves occupancy without cannibalizing higher-margin premium screens. The more important risk is scheduling friction: a crowded corridor with a strong female-skewing holdover and a live-event music title concentrates demand in specific demographics, which can leave broader-market product fighting for leftover showtimes. That dynamic tends to favor chains with better IMAX/PLF exposure and penalize locations dependent on standard-format traffic.

The contrarian view is that the market may be overfocusing on headline opening potential and underweighting the downstream revenue profile. A lower-than-feared launch can still be constructive if it limits front-loaded fan saturation and improves legs, especially for a property whose monetization depends on international play and PVOD later in the cycle. The bigger watch item is whether this confirms that theatrical-only demand for adult-skewing action sequels is stabilizing below pre-pandemic expectations, which would pressure greenlight economics across the studio slate over the next 6-12 months.

Key Decisions for Investors

• Short-term: sell any strength in exhibitor names most exposed to standard-format action attendance; prefer a relative short in AMC vs a long in a premium-format/IMAX-exposed basket over the next 1-2 weeks if opening weekend comes in below the high-end tracking range.
• Longer-term: use a weak debut in the action sequel to add to short positions in mid-budget studio content proxies where slate economics are most fragile; the risk/reward improves if this becomes part of a broader pattern of underwhelming genre openings over 1-3 months.
• Pair trade: long IMAX / short a diversified exhibitor with lower PLF mix for the next 30-60 days; if premium screens continue to capture the best-demand titles, IMAX should retain pricing power even in a mixed box-office tape.
• Optionality: buy small downside hedges on any studio/streaming proxy that is reliant on theatrical window returns if the film misses the lower end of internal expectations, since it could tighten capital allocation across upcoming franchise projects.
• Tactical watch: if the film’s weekend drop is steeper than 55%, fade any bounce in related media names; if it holds better than 50%, cover shorts quickly because the market will reprice leg potential within 3-5 trading days.